第一单位：
European Institute for Molecular Imaging, University of Münster, D-48149 Münster, Germany.
作者：
Cristina,Barca [1]
;
Christoph M,Griessinger [2]
;
Andreas,Faust [3]
;
Dominic,Depke [1]
;
Markus,Essler [4]
;
Albert D,Windhorst [5]
;
Nick,Devoogdt [6]
;
Kevin M,Brindle [7]
;
Michael,Schäfers [3]
;
Bastian,Zinnhardt [8]
;
Andreas H,Jacobs [9]
作者单位：
European Institute for Molecular Imaging, University of Münster, D-48149 Münster, Germany.
[1]
Roche Innovation Center, Early Clinical Development Oncology, Roche Pharmaceutical Research and Early Development, CH-4070 Basel, Switzerland.
[2]
European Institute for Molecular Imaging, University of Münster, D-48149 Münster, Germany.;Department of Nuclear Medicine, University Hospital Münster, D-48149 Münster, Germany.
[3]
Department of Nuclear Medicine, University Hospital Bonn, D-53127 Bonn, Germany.
[4]
Department Radiology & Nuclear Medicine, Amsterdam UMC, Vrije Universiteit, De Boelelaan 1117, 1081HV Amsterdam, The Netherlands.
[5]
In Vivo Cellular and Molecular Imaging Laboratory, Vrije Universiteit Brussel, B-1090 Brussel, Belgium.
[6]
Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 ORE, UK.
[7]
European Institute for Molecular Imaging, University of Münster, D-48149 Münster, Germany.;Department of Nuclear Medicine, University Hospital Münster, D-48149 Münster, Germany.;Biomarkers and Translational Technologies, Pharma Research and Early Development, F. Hoffmann-La Roche Ltd., CH-4070 Basel, Switzerland.
[8]
European Institute for Molecular Imaging, University of Münster, D-48149 Münster, Germany.;Department of Geriatrics and Neurology, Johanniter Hospital, D-53113 Bonn, Germany.;Centre of Integrated Oncology, University Hospital Bonn, D-53127 Bonn, Germany.
[9]
DOI
10.3390/ph15010013
PMID
35056071
发布时间
2024-02-10
换一批
换一批
